Organizational, Managerial and Control Model

The Italian regulations pertaining to the “Administrative liabilities of legal entities deriving from offences” contained with Legislative Decree no. 231 of 2001 (henceforth, “Decree”) states that legal entities may be held liable – and therefore sanctioned by financial means or criminal proceedings – in relation to certain crimes which are committed or attempted in Italy or abroad in the interest or for benefit of the Company.

Pursuant to this Decree, FIDIA FARMACEUTICI S.p.A. (henceforth, “Fidia”) has adopted an Organizational, Managerial and Control Model (henceforth, “Model”) suitable for preventing the crimes themselves, which is periodically revised and updated.

Click on the links below to read and download the documents which refer to Fidia’s Model, last updated on July 15, 2021:


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine